Some evidence suggests that taking tamoxifen after surgery for DCIS reduces the risk of breast cancer coming back in the same breast and a new breast cancer developing on
Tamoxifen belongs to a class of drugs known as selective estrogen receptor modulators (SERMs)
Tamoxifen is also used after surgery to reduce the risk of invasive breast cancer in women who have been diagnosed with hormone receptor-positive DCIS
We aimed